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Abstract
Background: Several Western and Arab countries, as well as over 30 States in the US are using the “All-Patient
Refined Diagnosis-Related Groups” (APR-DRGs) with four severity-of-illness (SOI) subcategories as a model for
hospital funding. The aim of this study is to verify whether this is an adequate model for funding stroke hospital
admissions, and to explore which risk factors and complications may influence the amount of funding.
Methods: A bottom-up analysis of 2496 ischaemic stroke admissions in Belgium compares detailed in-hospital
resource use (including length of stay, imaging, lab tests, visits and drugs) per SOI category and calculates total
hospitalisation costs. A second analysis examines the relationship between the type and location of the index stroke,
medical risk factors, patient characteristics, comorbidities and in-hospital complications on the one hand, and the
funding level received by the hospital on the other hand. This dataset included 2513 hospitalisations reporting on
35,195 secondary diagnosis codes, all medically coded with the International Classification of Disease (ICD-9).
Results: Total costs per admission increased by SOI (€3710–€16,735), with severe patients costing proportionally more
in bed days (86%), and milder patients costing more in medical imaging (24%). In all resource categories (bed days,
medications, visits and imaging and laboratory tests), the absolute utilisation rate was higher among severe patients,
but also showed more variability.
SOI 1–2 was associated with vague, non-specific stroke-related ICD-9 codes as primary diagnosis (71–81% of
hospitalisations). 24% hospitalisations had, in addition to the primary diagnosis, other stroke-related codes as secondary
diagnoses. Presence of lung infections, intracranial bleeding, severe kidney disease, and do-not-resuscitate status were
each associated with extreme SOI (p < 0.0001).
Conclusions: APR-DRG with SOI subclassification is a useful funding model as it clusters stroke patients in
homogenous groups in terms of resource use. The data on medical care utilisation can be used with unit costs from
other countries with similar healthcare set-ups to 1) assess stroke-related hospital funding versus actual costs; 2) inform
economic models on stroke prevention and treatment. The data on diagnosis codes can be used to 3) understand
which factors influence hospital funding; 4) raise awareness about medical coding practices.
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Background
Stroke is one of the leading causes of morbidity and dis-
ability in adults [1], with total acute care costs in the first
year after stroke varying between €5435 and €13,409 per
patient [2–6], representing 2–4% of total health care ex-
penditures [7]. In many countries these medical care costs
are mainly funded by a national insurance system, creating
the need for an efficacious and equitable funding system
balancing the financial risks born by the provider and the
National Health System with the health risk born by the
patient. Many countries fund hospitals through derivatives
from the Diagnosis Related Groups (DRG) [8], a classifica-
tion system aiming to group homogenous diagnostic pa-
tients with equivalent use of hospital resources to calculate
the “average” cost of a hospitalisation in order to assign the
correct amount of funding to the health care provider [9].
Some, but not all, DRG systems provide a further div-
ision into subcategories for a better match between the
funding received and the expenses made by hospitals for
treating the patient [10]. In the All Patient Refined
(APR)-DRG system, the basic DRG structure is ex-
panded with 4 subclasses relating to severity of illness
(SOI) [10]. This particular classification is applied as a
model for reimbursement in over 30 different states in
the US, and also in Belgium, Spain and Italy, and in
some Arab countries [11]. The 4 SOI subclasses repre-
sent respectively, minor, moderate, major or extreme
physiologic decompensation or loss of function of an
organ system. Extreme SOI is usually associated with
multiple comorbidities involving 2 or more organ sys-
tems [12], and is assigned to patients with poor out-
comes in spite of receiving more frequent and intensive
treatment. The distribution of hospital admissions across
these subclasses within a DRG has a substantial impact
on hospital budgets as well as on public health care ex-
penditure on stroke. Gaining insight into the factors that
determine the categorisation of stroke patients into sub-
classes of the DRG is therefore relevant for hospitals as
well as public authorities.
This study first aims to document actual resources used
in hospital by ischaemic stroke patients and to verify to
which extent this varies according to SOI categories, in
order to assess whether the division into DRG subcategor-
ies is indeed justified. The second objective is to explore
which medical risk factors and complications are signifi-
cantly related to higher SOI and thus higher funding.
Methods
Two datasets were obtained in order to address the two
aims of this study:
Analysis of in-hospital resource use by SOI
To compare resource use by SOI, retrospective aggre-
gate data on ischaemic stroke admissions classified as
APR-DRG 045 “CVA and precerebral occlusion with in-
farct” from the administrative department of 5 Belgian
hospitals were obtained for the years 2008 up to 2011,
reporting on the total number of bed days, number and
type of medical imaging and clinical biology tests, and
drug expenditures for their admitted patients, by SOI.
Participating hospitals were distributed across the coun-
try and included regional as well as teaching hospitals.
Average bottom-up costs were calculated according to
the recommended method by the Belgian Health Care
Knowledge Centre [13, 14]. The unit costs applied to
each resource item took into account three different
financing sources received by hospitals for each in-
patient admission: the fee-for-service [13, 14] received
from the National Compulsory Insurance Fund, patient
contribution per day or per admission [13, 14], and lump
sum payments paid on a yearly basis by the National In-
stitute for Health and Disability Insurance (NIHDI). The
latter – lump sum payments – was calculated by apply-
ing a multiplication factor to the unit costs, derived by
the ratio between the historical national average of total
funding for a given resource category and the total fee-
for-service payments. This factor was estimated to ap-
proximate 5.0 for laboratory tests and 1.7 for imaging
[13]. Detailed data on specialists visits was not available,
therefore the cost of these visits was approximated by
the standard reimbursement tariff for routine visits [14].
This tariff is derived from a calculation based on the
length of stay with degressive amounts paid for longer
stays. The reference year for the costs was 2014. Total
bottom-up costs were calculated per hospital admission
and per SOI level and were compared to the top-down
national reimbursement received by hospitals for a
stroke admission. The national aggregate data on 14,911
ischaemic stroke admissions (APR-DRG 045) was ob-
tained from the Belgian TCT database (2011) [15] and
used for comparison with our sample. This national
registry collects the medical diagnoses anonymously
from all patients that are admitted overnight to all acute
Belgian hospitals and the costs charged to the NIHDI
for each admission.
Analysis of primary and secondary diagnosis codes by SOI
All ischaemic stroke patients who were admitted be-
tween 2008 and 2014 to the largest teaching hospital in
Belgium (UZ Leuven) were included in a second dataset.
Ischaemic stroke hospitalisations were identified by fil-
tering on the APR-DRG code “045 CVA & Precerebral
Occlusion with Infarct”, with specification of a primary
diagnosis code “433.x Occlusion and stenosis of precer-
ebral arteries” or “434.x Occlusion of cerebral arteries”.
These codes are based on the International Classification
of Diseases, Version 9, Clinical Modification (ICD-9). In
addition, the dataset included ICD-9 codes of the event
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leading to the hospitalisation, of pre-existing comorbidi-
ties, of in-hospital complications, of surgical or medical
procedures, of short- and long term sequelae, and of age
and gender of the patient, which are all labelled as sec-
ondary diagnoses. A proprietary algorithm created by
3M Health Information Systems (APR-DRG v15.0) com-
bined these primary and secondary diagnoses codes to
assign a DRG and SOI to each admission [12]. This cod-
ing algorithm is not published, and not known to the ad-
ministrative department of the hospital responsible for
the coding of the medical files. All diagnosis codes asso-
ciated with higher SOI levels, and therefore higher reim-
bursement, were identified. A Poisson regression with
log link compared the occurrence of diagnosis codes
between the higher and the lower SOI levels, and in
cases with low cell count Fisher’s exact testing was
applied. All analyses were conducted in SAS. No funding
was received for this study.
Results
Analysis of in-hospital resource use by SOI
In this bottom-up costing analysis, 2496 stroke admis-
sions were included. Of these, all admissions accounted
for length of stay (LOS) calculations, 2364 for medical
imaging, and 1954 for medications whereas data for
honoraria to specialists were not available. In total, the
sample captured 4.3% of all ischaemic stroke hospital ad-
missions in Belgium during that period [15]. The average
costs incurred during stroke admission for LOS, special-
ist visits, medications, medical imaging and clinical biol-
ogy tests for each SOI level are detailed in Table 1.
The most frequently assigned subcategories were SOI
2 and SOI 3, representing 78.2% of all stroke admissions.
The average LOS in an acute ward had a strong associ-
ation with SOI and represented 67, 77, 83 and 86% of
total costs in SOI 1 to 4, respectively; its variability also
increased with higher SOI levels. Average spending on
medications varied also by SOI, with drug costs in SOI 4
being 5.5 times higher compared to SOI 1, representing
between 4 and 5% of total costs in all SOI classes. On
average 15 types of laboratory tests were used including
haematology tests, coagulation, renal and liver function
tests, electrolytes, heart enzymes, glucose and lipid
profiles as well as C-reactive protein (details in
Additional file 1: Table S1). These resources did not dif-
fer by SOI in our dataset and were part of a general
work-up at admission (0.4–1.7% of total costs). A total
of 39 different medical imaging and other tests were
used during stroke hospitalisations, including functional
measurements, Holter tests, angiography, arteriography,
echography, duplex ultrasonography, electromyography,
electroencephalography, radiology, x-rays, computed
tomography and magnetic resonance imaging. The rate
of use of each test by SOI is displayed in Additional file 2:
Table S2, and also increases by SOI: higher SOI is asso-
ciated with a higher number of diagnostic imaging tests
and higher associated costs. This cost component,
though increasing with SOI, represented a smaller pro-
portion of total costs in more severe subclasses (24, 15,
10 and 7% of total costs in SOI 1 to 4, respectively).
Total costs were found to be significantly associated
with SOI, with the most severe stroke (SOI 4) being 4.5
times more expensive than a mild case (SOI 1).
Table 2 displays the national average health care ex-
penditures for ischaemic stroke patients in 2011 [15].
The distribution of stroke admissions across the differ-
ent SOI levels in our bottom-up analysis was not
dissimilar to the national distribution, with mild hospita-
lisations being slightly under-represented in favour of se-
vere hospitalisations (Table 1 compared with Table 2).
The average LOS from our bottom-up approach was
lower as compared to the national top-down approach
(17.3 vs 18.6 days). Summing up the categories specialist
visits, medical imaging and clinical biology, average cost
Table 1 Average hospitalisation cost of ischaemic stroke by SOI based on the retrospective dataset (bottom-up cost)
Retrospective aggregate data (2008–2011) SOI 1 SOI 2 SOI 3 SOI 4 ALL
Number of stroke admissions 98 1292 659 447 2496
% 3.9% 51.8% 26.4% 17.9% 100%
Average LOS in days (SD) 6.06 (1.28) 10.81 (1.22) 19.74 (7.14) 35.23 (12.52) 17.34 (4.48)
LOS costa €2480 €4371 €7972 €14,352 €7032
Medications €143.58 €156.96 €361.75 €780.25 €324.22
Visitsb €138.81 €178.36 €220.51 €284.96 €210.54
Clinical biologyc €64.54 €64.54 €64.54 €64.54 €64.54
Medical imagingd €882.78 €872.49 €936.27 €1253.65 €963.01
Total cost per stroke admission €3710 €5643 €9555 €16,735 €8594
SOI: severity of illness, SD: standard deviation; LOS: length of stay
aClaims data, average of €406.96 per day
bApproximated by reimbursement tariff: calculated as €26.00 for days 1–5; €8.33 for days 6–12 and €4.16 thereafter
cSee calculations Additional file 1: Table S1
dSee calculations Additional file 2: Table S2
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per stroke admission was approximately €1238 per pa-
tient in our analysis compared to the national average
category of “honoraria” of €1909 per patient. This hon-
oraria category includes in addition to the types of re-
sources incorporated in our study (specialist visits,
medical imaging and clinical biology) also medical pro-
cedures, medical night supervision, implants and pros-
theses, and a rest category covering among others
incontinence material, blood, radio isotopes, implants
and others. These resources were not recorded in our
bottom-up approach. Total cost per stroke admission in
the bottom-up analysis (€8594) was about 5% lower
compared to the national average (€8987). This is more
pronounced in SOI 2 and SOI 3, where the total
bottom-up costs are respectively 12.4 and 12.8% lower
compared to the national average, and less pronounced
in SOI 4 (− 1.9%) and SOI 1 (+ 2.6%).
Analysis of primary and secondary diagnosis codes by SOI
Primary diagnosis codes (location and type of the ischaemic
stroke)
A total of 2513 stroke admissions were recorded during
the study period 2008–2014, distributed across SOI clas-
ses as follows: 52 (2.0%) in SOI 1; 1233 (49.1%) in SOI 2;
797 (31.7%) in SOI 3; and 431 (17.2%) in SOI 4. Each ad-
mission was associated with a single primary diagnosis
related to the reason for admission, and one or more
secondary diagnoses related to comorbidities, complica-
tions, procedures, and patient characteristics.
The distribution of patients across each stroke-related
primary diagnosis code is displayed in Table 3. One of the
primary ICD-9 diagnosis codes related to the cerebral ar-
teries was non-specific on the type of the event (throm-
bosis or embolism) and non-specific on the location in the
brain (“Unspecified occlusion of the cerebral artery, with
mention of brain infarct” ICD-9434.91), whereas other
ICD-9 codes were differentiated into thrombosis, embol-
ism, or occlusion and stenosis; or were more precise on
the location of the stroke, which may influence the long-
term deficits patients can experience. On average, 64.5% of
ischaemic strokes were attributed to this non-specific cat-
egory (Table 3), but this was significantly more frequent in
lower SOI categories (p < 0.0001), with up to 81 and 71%
of hospitalisations in SOI 1 and 2 respectively being
assigned this code as primary diagnosis. The other primary
diagnosis codes were more specific on either the type of
event or the location of the stroke, but no relationship was
found between each individual stroke code and higher SOI.
Table 2 National average hospitalisation cost of ischaemic stroke by SOI (top-down cost)
National aggregate data (2011) SOI 1 SOI 2 SOI 3 SOI 4 ALL
Number of stroke admissions 785 7910 4235 1981 14,911
% 5.3% 53.0% 28.4% 13.3% 100%
Average LOS (days) 6.6 13.1 23.7 34.4 18.6
LOS cost €2452.93 €4779.79 €8472.71 €12,910.79 €6786.39
Medications €71.69 €151.05 €307.12 €903.69 €291.19
Visits, clinical biology and medical imaging €1091.64 €1510.84 €2182.44 €3238.36 €1909.03
Total cost per stroke admission €3616 €6442 €10,962 €17,053 €8987
SOI: severity of illness, LOS: length of stay
Source: Belgian TCT database, 2011(15)
Table 3 Primary diagnosis codes associated with APR-DRG 045 ischaemic stroke
Description of primary diagnosis codes within APR-DRG 045 % of total Distribution per SOI
SOI 1 SOI 2 SOI 3 SOI 4
N 2513 52 1233 797 431
% 100.0 2.0 49.1 31.7 17.2
Unspecified occlusion of the cerebral artery, with mention of brain infarct (ICD 434.91)a 64.5% 80.8% 71.0% 58.9% 54.5%
Cerebral embolism, with mention of brain infarct (ICD 434.11) 21.9% 7.7% 17.6% 28.1% 24.4%
Occlusion and stenosis of the carotid artery, with mention of brain infarct (ICD 433.11) 6.2% 7.7% 5.0% 6.2% 10.0%
Cerebral thrombosis, with mention of brain infarct (ICD 434.01) 2.8% 1.9% 1.8% 2.8% 5.8%
Multiple and bilateral occlusion and stenosis of the precerebral arteries, with brain infarct (ICD 433.31) 1.8% 1.9% 1.5% 1.6% 2.6%
Occlusion and stenosis of the basilar artery, with mention of brain infarct (ICD 433.01) 1.6% 0.0% 1.5% 1.5% 2.3%
Occlusion and stenosis of the vertebral artery, with mention of brain infarct (ICD 433.21) 1.2% 0.0% 1.6% 0.9% 0.5%
Occlusion and stenosis of other specified precerebral arteries, with brain infarct (ICD 433.81) 0.1% 0.0% 0.1% 0.1% 0.0%
ICD: International Classification of Diseases, SOI: severity of illness
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Secondary diagnosis codes (comorbidities and complications)
A total of 35,195 secondary codes were retrieved from the
dataset representing 2241 unique ICD-9 codes. As ex-
pected from the SOI definition, we found a significant
positive relationship between the average number of sec-
ondary diagnoses per admission and the SOI: on average
4.1 secondary diagnoses were assigned per ischaemic
stroke admission in SOI 1, 9.9 in SOI 2, 16.5 in SOI 3 and
22.4 in SOI 4, clearly indicating that the involvement of
multiple organ systems leads to higher severity levels.
Typical risk factors in ischaemic stroke patients in-
clude previous myocardial infarction, diabetes, atrial fib-
rillation, hypertension, hypercholesterolaemia, smoking
and atherosclerosis. Most of these risk factors were
found not to be individually linked to more severe SOI
levels, as they were present across all SOI levels (Table 4)
, apart from atrial fibrillation and diabetes. Even though
the sample size was small in SOI 1, none of these pa-
tients had atrial fibrillation or diabetes. Atrial fibrillation
is a comorbidity typically occurring in up to 30% of
stroke patients [16, 17], and therefore should presumably
have been found in about 15 patients in our SOI 1 sam-
ple. Similarly, the prevalence of diabetes in stroke pa-
tients ranges from 13.2 to 36.9% which corresponds with
7 to 19 of the 52 patients in our SOI 1 sample [17–19].
Statistical testing with Fisher’s exact test confirmed that
this was not a sampling problem but instead that these
two risk factors are structurally linked to a SOI level of
at least 2. The other typical stroke comorbidities such as
previous myocardial infarction, hypertension, hyperchol-
esterolaemia, smoking and atherosclerosis do not indi-
vidually lead to the attribution of a higher SOI, but the
combination of these comorbidities however will gener-
ate a higher SOI assigned to the hospitalisation. The
most commonly observed secondary codes in ischaemic
stroke patients were hypertension (60%), hypercholester-
olaemia (60%), hemiplegia, monoplegia or paraplegia
(59%), speech disorder (56%), apraxia, dysphagia, ataxia,
vertigo or cognitive dysfunction (35%) (Table 4).
The high number of hospital admissions that have an-
other stroke-related ICD-9 code as one of the secondary
codes is noteworthy. About 24% (607/2513) of patients
had one or more secondary stroke diagnosis codes in
their electronic DRG file.
Table 5 displays a list of secondary codes occurring
significantly more in SOI 3 and SOI 4 as compared to
lower SOI levels. These represent comorbidities that
mostly occur in the highest severity levels and are indi-
cative of multiple organ systems affected and higher re-
source utilisation. The comorbidities included, among
others, pneumonitis, pneumonia, intracranial haemor-
rhage, renal insufficiency and do-not-resuscitate status
for SOI 4; and neurological complications, anaemia,
Urinary Tract Infection (UTI), hypokalaemia and heart
failure or heart decompensation for SOI 3 and 4. These
codes will lead to the attribution of a higher severity
level, and thus higher funding for hospitals.
Discussion
SOI subclassification of DRG to fund ischaemic stroke
admissions is meaningful
Our first analysis on in-hospital resource utilisation
compared the types (bed days, medical imaging, medica-
tions, specialist visits, and clinical laboratory tests) and
the amount of medical resources used per patient at
each SOI level, and showed that in absolute terms as
well as proportionally these varied substantially between
SOI categories. More severe patients had proportionally
more bed day costs and fewer imaging costs than milder
patients, however they consumed a higher amount of re-
sources across all categories. These findings indicate that
ischaemic stroke patients are heterogeneous in their
medical care consumption, and a split of the DRG in
SOI subcategories to obtain groups of patients who are
more homogenous in their resource use, is justified for
ischaemic stroke admissions. In addition, we observed
that the mix of resources used at different SOI levels
also lead to differences in total costs, therefore subcate-
gorisations into SOI will lead to more efficient funding
within each category. When hospitals have the same pa-
tient distribution across SOI as in the national dataset,
funding of ischaemic stroke hospitalisation with a single
DRG code is adequate. But when hospitals admit pro-
portionally more patients with higher severity of illness,
they will be underfunded when receiving only a uniform
payment per patient.
Our dataset spanned 4 years’ time and within this
time, no major shifts were recorded in terms of re-
sources used per SOI. The detailed documentation of
these resources can be used with unit costs from juris-
dictions with similar health care set-ups to estimate in-
hospital costs. These costs can be used in economic
models and health-care evaluations to estimate costs of
stroke prevention or acute stroke care, or to better allo-
cate health care resources. Many states in the US fund
their hospitals in part through the APR-DRG-SOI algo-
rithm. In contrast to many European countries, the care
given to patients in the US may differ whether they fall
under Medicaid (19% of the population), Medicare (14%)
, an employer-subsidized health plan (49%), a privately
paid health plan (7%), or are uninsured (11%) [20]. It
may be possible that the medical resource utilization we
calculated by SOI, differs within each SOI category by
the insurance status of the patient. There is evidence
among stroke patients that insured patients [21] arrive
earlier after symptom onset to the hospital and are more
likely to arrive in ambulance, compared to un-insured
patients. Patients with insurance are also more likely to
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be treated in designated primary stroke centers and
more likely to be discharged to inpatient rehab facility.
No difference was found however in length of stay in the
acute hospital, in prescription of drugs, in stroke educa-
tion given, or in any of the stroke outcome measures:
the severity of disease at arrival (measured with the NIH
Stroke Scale) or disability level at discharge (measured
with the modified Rankin Scale) by insurance status. In
Belgium, all patients are mandatorily insured through
the tax-funded, national health care system, and in
addition to that an estimated 80% have a complimentary
hospitalization insurance covering the difference be-
tween the actual hospitalization costs and what is reim-
bursed by the compulsory insurance. These insurances
are contracted in 50% of cases by employers, in 33%
taken by patients as an additional insurance with their
sickness fund and in 17% of cases patients pay for an in-
dividual health insurance plan [22, 23]. Future research
could focus on whether the resources found in this study
differ within each SOI category by insurance status; un-
fortunately this data was not available in our dataset.
DRG-based funding for hospital admissions thus per-
forms best when the variability in resources used by pa-
tients during a hospital admission is low, because costs
are predictable and the financial risk can be managed
equitably between the provider and the payer. The
Belgian Health Care Knowledge Centre (KCE) published
a study to investigate which APR DRG-SOI have low
variability and are particularly suited to have full DRG
funding [24]. In APR-DRG 045 ischaemic stroke, two
Table 4 Secondary codes by SOI occurring in at least 10% of all ischaemic stroke patients
Description of secondary diagnosis code SOI 1 SOI 2 SOI 3 SOI 4 ALL
Number of stroke admissions 52 1233 797 431 2513
Typical stroke risk factors
Atherosclerosis 9.6% 17.7% 21.5% 20.0% 19.1%
Arrhythmia and other dysrhythmia 7.7% 14.1% 18.1% 18.3% 16.0%
Atrial fibrillation 0.0% 18.4% 45.9% 45.5% 31.4%
Diabetes 0.0% 19.1% 26.7% 29.2% 22.8%
Obesity, overweight 1.9% 16.4% 17.6% 10.0% 15.4%
Hypertension 40.4% 62.4% 58.2% 55.9% 59.5%
Hypercholesterolaemia/ hyperlipidaemia 21.2% 67.8% 56.5% 49.2% 60.0%
Smoking 23.1% 20.6% 10.9% 10.4% 15.8%
Previous myocardial infarction 1.9% 8.2% 12.8% 16.9% 11.0%
Previous stroke 7.7% 14.6% 16.6% 16.0% 15.3%
Other secondary diagnosis codesa
Hemiplegia, paraplegia, monoplegiab 7.7% 50.1% 65.6% 78.2% 59.0%
Speech disorderb 17.3% 48.8% 60.0% 71.5% 55.6%
Apraxia, dysphagia, ataxia, vertigo, cognitive dysfunction 19.2% 29.0% 34.1% 53.6% 34.6%
Facial paralysisb 9.6% 29.8% 35.6% 42.5% 33.4%
Mental illnessc 1.9% 12.4% 29.5% 36.4% 21.7%
Long term use of anti-coagulation 1.9% 14.9% 26.0% 23.4% 19.6%
Loss of half of the visual field in both eyes 0.0% 9.7% 27.4% 27.6% 18.2%
Living alone 7.7% 10.2% 17.9% 23.7% 14.9%
Mitral and/or aorta valve stenosis or insufficiency 3.8% 8.5% 17.4% 20.9% 13.4%
Atrial septal defect 0.0% 14.7% 10.7% 5.6% 11.5%
Hypertensive Chronic Renal disease 0.0% 5.9% 15.1% 17.9% 10.7%
Cancer: neoplasm, lymphoma, carcinoma, myeloma, metastases 1.9% 6.6% 12.0% 16.0% 9.8%
Stroke-related secondary diagnosis
Any stroke-related diagnosis ICD-9 coded 11.5% 21.2% 24.5% 32.7% 24.0%
ICD: International Classification of Diseases, SOI: severity of illness
aDiagnosis codes including: pre-existing co-morbidities, in-hospital complications, patient characteristics, medical care
bNeurological deficits due to stroke
cIncluding dementia, delirium, Alzheimer, delirium, cognitive dysfunction
dIncluding all 433.x and 434.x ICD-9 codes and subcategories
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SOIs were found to have very predictable resource util-
isation: the least frequent category SOI 1 (5%), and the
most frequent category SOI 2 (53%). For those SOI
levels it was found that most hospitals have procedures
on how to manage these patients, and moreover that
these procedures do not vary much between hospitals,
resulting in low variability within and between hospitals
in reimbursement level and in LOS data. However, for
higher SOI levels 3 and 4 within APR-DRG 045 ischae-
mic stroke, the variability within a hospital and between
hospitals was found to be considerably larger, indicating
that patient characteristics and comorbidities vary more
widely and there are also more differences between
hospitals in how much resources are used to manage
these patients. In our dataset, the variability in LOS in
the SOI 1 and 2 was markedly lower than in the higher
SOI classes, confirming these findings. As the latter
patient groups are less homogenous in their used re-
sources, fully funding these patients on the basis of a
diagnosis-related categorisation is more challenging. Our
data also confirmed the finding that patients in higher
SOI levels have more comorbidities per person and have
comorbidities affecting different organ systems resulting
in a higher amount of medical resource utilisation. Differ-
entiating the APR-DRGs by severity is a necessity in order
to determine the appropriate level of funding for the hos-
pitals who are managing these patients.
The use of stroke-related diagnosis codes
Two results emerging from the ICD-9 code analysis
merit highlighting.
Firstly, nearly two thirds of all ischaemic stroke hospita-
lisations were assigned a primary diagnosis code that was
not event-specific (ICD-9 434.91, 64.5%). The use of more
specific ICD-9 codes on the type of event (thrombosis or
embolism of the cerebral arteries; or occlusion and sten-
osis of the precerebral arteries) as primary diagnosis was
associated with higher SOI thus higher funding. More se-
vere SOI categories were also found to be related to higher
use of diagnostic imaging tests in our first analysis, which
could explain the ability of the hospital to be more precise
on the localisation of the ischaemia in the brain. However,
higher SOI could not be individually associated with one
of the more specific stroke codes.
Secondly, we observed frequent use of stroke-related
ICD-9 codes as secondary diagnoses in our dataset
(24%). This indicated that the same stroke was coded
multiple times in the medical file within the same epi-
sode of care. This multiple stroke coding could be an in-
dication of another ischaemia found in another location
of the brain, in addition to the first event mentioned in
the primary diagnosis code, which is clinically possible
but not as frequently as found in this dataset. Another
explanation for this multiple stroke coding is the fact
that in the APR-DRG system every speciality/ward type
Table 5 Secondary diagnosis codes occurring more frequently in SOI 3 and SOI 4
Occurring significantly more frequently in SOI 4 SOI 1 N = 52 SOI 2 N = 1233 SOI 3 N = 797 SOI 4 N = 431 p-valueb
Pneumonia 0% 0% 6% 30% < 0.0001
Pneumonitis 0% 0% 4% 28% < 0.0001
Palliative care 2% 3% 7% 20% < 0.0001
DNR status 0% 1% 7% 16% < 0.0001
Intracranial haemorrhage 0% 0% 6% 15% < 0.0001
Feeding problems, malnourishment 0% 0% 1% 12% < 0.0001
Renal insufficiency (acute and chronic) 0% 0% 2% 7% < 0.0001
Occurring significantly more frequently in SOI 3 and SOI 4 SOI 1 N = 52 SOI 2 N = 1233 SOI 3 N = 797 SOI 4 N = 431 p-valuec
Infection 2% 2% 33% 65% < 0.0001
Neurologic complicationsa 0% 1% 15% 40% < 0.0001
Urinary tract infection 0% 1% 22% 29% < 0.0001
Anaemia 0% 5% 13% 27% < 0.0001
Rehabilitation 0% 7% 17% 25% < 0.0001
Heart failure and heart decompensation 0% 0% 15% 23% < 0.0001
Hypokalaemia 0% 3% 14% 20% < 0.0001
Pulmonary heart disease 0% 0% 5% 8% < 0.0001
Oesophagitis 0% 1% 3% 8% < 0.0001
SOI: severity of illness, DNR: do not resuscitate
aUnconsciousness, coma, cerebral compression, cerebral oedema
bp-value for Likelihood Ratio test type 3 from a Poisson Log model: SOI 4 versus SOI 1, SOI 2 and SOI 3 combined
cp-value for Likelihood Ratio test type 3 from a Poisson Log model: SOI 3–4 combined versus SOI 1–2 combined
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in the hospital must assign a primary diagnosis code
when a patient is admitted, and that the final DRG code
of the hospitalisation is assigned by a coding specialist
after discharge of the patient, based on the combined
primary and secondary codes from each speciality/ward
type in the medical file. Stroke patients typically enter
the hospital through the Accident & Emergency (A&E)
department (first speciality), followed by an admission in
a neurological ward (second speciality). Some patients
move on to a rehabilitation ward (third speciality),
resulting in three primary diagnosis codes that are not
necessarily identical. The A&E department is more likely
to assign a non-specific stroke code at admission,
whereas the neurology department will assign an event-
specific or location-specific stroke ICD-9 code following
imaging tests. The rehabilitation ward may focus more
on neurological deficits as primary reason for admission
into the ward. Only one of these primary diagnosis codes
will be retained as the DRG-determining code (that will
also determine the funding for the hospital), whereas the
other codes may be retained as secondary diagnosis
codes (determining the SOI). The 3M coding algorithm
allows for these ward-specific coding practice and should
correct for the double-counting of stroke codes. The
final explanation of the multiple coding of stroke is the
upcoding of a patient’s medical file in order to enhance
funding for the hospital. However, given the complexity
of the ward-specific coding, the imprecision of the
ICD-9 coding system regarding ischaemic stroke
(allowing to specify the location of the ischaemia in the
precerebral arteries but not in the cerebral arteries) and
the proprietary nature of the 3M algorithm, this is
difficult to disentangle.
Secondary codes and their relationship with the funding level
Comorbidities occurring frequently among stroke pa-
tients and leading to a higher funding level are atrial fib-
rillation and diabetes; whereas other risk factors such as
a history of stroke and/or myocardial infarction, athero-
sclerosis, hypertension, hypercholesterolaemia,... to
which neurologists usually take into account when mak-
ing their treatment decisions did not automatically lead
to higher funding for the hospital. A list of other comor-
bidities and complications were identified that were sig-
nificantly more related to SOI levels of 3 and 4,
including lung infections, renal insufficiency, end-of-life
status and others. Not surprisingly, we found that the
total number of comorbidities entered in the patient’s
file determine the severity level of the admission. These
findings demonstrate the importance for hospitals of
collecting exhaustive information on pre-existing comor-
bidities, and updating the patient’s medical file when
additional clinical information becomes available on any
complications or comorbidities. But equally, from the
view point of the National Health System, it is important
to create sufficient quality checks on the coding to avoid
misuse of the system by double-coding or up-coding ad-
missions to a higher severity level in order to increase
funding. Ensuring high-quality data collection and
investing in medical coding is a necessity in order to at-
tribute the correct amount of funding for the case mix
of patients. This raises interesting questions and chal-
lenges regarding the governance set-up of DRG systems,
turning the spotlight on the need for accurate data col-
lection and coding if the key principle of DRG systems is
to be achieved: to balance the financial risk between the
health care provider and the payer.
Limitations of the study
We used two different datasets to draw our conclusions,
and both have limitations. The first dataset with resource
use data was based on amounts of use for each type of re-
source, per year and per hospital. This made it difficult to
calculate confidence intervals for total costs; as no correl-
ation data was available between the many different types
of resources within each category. We were able to report
the variability around LOS, and this variable was the most
important component of total costs.
Another caveat should be entered, as the selection
process for creating our second dataset on primary and
secondary ICD-9 codes by APR-DRG/SOI was based on
the primary diagnosis group being APR-DRG "045 Is-
chaemic stroke", which could be a limitation. A study by
Tirschwell and colleagues demonstrated that reported
stroke outcomes depended on the administrative selec-
tion process of the records [25]. The authors found that
excluding patients with an ischaemic stroke diagnosis in
a non-primary position resulted in underestimation of
the hospitalisation cost. Furthermore, this analysis was
performed in a single academic centre. Statistically sig-
nificant findings were recorded, but the results from this
study need to be replicated and, ideally, expanded upon
using larger study samples.
We also used data based on the ICD-9 coding of
medical information; many countries including Belgium
have recently moved onto ICD-10 coding but national
data based on ICD-10 will not be available for a num-
ber of years (in Belgium this is expected from 2018 on-
wards). Mapping functions exist between ICD-9 and
ICD-10 [26], but are not always 1-on-1, therefore some
ICD-9 codes have more than one corresponding code
in the ICD-10 classification, hence the difficulty of
transposing our results onto the newer system. Using
this mapping function, the ICD-9 code 434.91
“Unspecified occlusion of the cerebral artery, with men-
tion of brain infarct” that was most frequently used as
primary diagnosis code in our dataset, but has the dis-
advantage of being non-specific regarding the type of
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event and its location in the cerebral arteries, can be
mapped onto the unique ICD-10 code I63.50 “Cerebral
infarction due to unspecified occlusion or stenosis of
unspecified cerebral artery”. This confirms the impreci-
sion of this stroke diagnosis code: it is imprecise about
the type of event, as well as its location in the territory
of the cerebral arteries. These arteries can be technic-
ally subcategorised into the following locations: anterior
cerebral artery, middle cerebral artery, posterior cere-
bral artery (each of those split up between right, left, or
bilateral location), cerebellar artery, other cerebral ar-
tery or “unspecified” cerebral artery. The new coding
provides a different ICD-code for each event type
(thrombosis or embolism) and for each of these loca-
tions. ICD-10 is therefore much more precise in the lo-
cation of the ischaemia, which will result in more
accurate, location-specific and event-type specific cod-
ing of the stroke, which in turn will lead to better attri-
bution of funding.
Policy implications
Creating severity subcategories of the APR-DRG “045
Ischaemic stroke”, which are defined by the number of
organ systems affected rather than by the severity of
the stroke itself, is a useful classification system that
will cluster stroke patients into more homogenous
groups in terms of resource use, and thus lead to a
more efficient funding of these hospital admissions.
Many countries using DRG-classifications as a funding
model try to break down patients into smaller, more
uniform clusters, either by creating subdivisions of the
DRG, such as the SOI discussed in this study (used in
30 states in the US, Belgium, Spain, Italy, and in some
Arab countries); or by creating a higher number of base
DRGs (for example Germany creating 5000 base DRGs,
the Dutch DOT system has 3000 DRGs); or by associat-
ing complication levels (no, minor, major complica-
tions) to the main DRG (such as done in US states
using MS-DRG, in France with GHM, in Portugal with
AP-DRG). Of all these systems, the APR-DRG with SOI
is the most refined and advanced, collecting data on the
principal diagnosis, age, interactions of multiple sec-
ondary diagnoses, and combinations of non-operating
procedures with principal diagnosis, which is not avail-
able in these other systems. Moreover, its data structure
and coding methodology enables to easily retrieve pa-
tients with specific conditions across different DRGs,
which is particularly suitable for “population manage-
ment”, i.e. preventive medicine in targeted populations.
The identification of patients with particular chronic
conditions for example is not possible or more difficult
in the other systems, mainly due to their more limited
data collection but also due to their data structure not
allowing to query across different DRGs.
Conclusion
In conclusion, an efficient funding system for ischaemic
stroke hospitalisations should be based on clustering pa-
tients with similar needs of medical resources. The APR-
DRG system with SOI subcategories classifies patients
according to their primary (stroke) diagnosis plus a wide
range of secondary diagnoses into four severity levels.
Each severity level requires a different mix of resources
necessary to manage the patient’s stroke plus any other
affected organ systems, and will therefore lead to a dif-
ferent need of funding. Selected comorbidities were
found to be associated with higher SOI, and hence
higher funding received by hospitals. Ensuring high-
quality data collection and investing in medical coding is
a necessity to attribute the correct amount of funding
for the case mix of patients.
The detailed data on medical care utilisation reported
by severity level can be used in conjunction with unit
costs from other countries with similar healthcare set-ups
to 1) assess stroke-related hospital funding versus actual
costs; 2) estimate the cost-effectiveness and budget impact
of stroke prevention measures and treatment. The data on
diagnosis codes and their link with SOI can be used to 3)
understand which factors apart from stroke severity can
influence the funding received by hospitals; 4) raise aware-
ness about medical coding practices and double-coding
coding to influence hospital funding.
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